Data / Form D filings / Willow Neuroscience, Inc.
Willow Neuroscience, Inc.: Form D filings
Willow Neuroscience, Inc., a biotechnology company in Palo Alto, CA, filed 3 Form D notices with the SEC between 2017 and 2023. The latest, on July 10, 2023, reports $2.1 million sold of a $3.3 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- c/o Alexandria Launch Labs, 3160 Porter Dr., Palo Alto, CA, 94304
- Phone
- (510) 588-8840
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1701524
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 10, 2023 | Amendment | $3,250,000 | $2,074,500 | $1,175,500 | 19 | Jan 6, 2016 | sec.gov |
| Jan 18, 2022 | New notice | $3,250,000 | $2,024,500 | $1,225,500 | 19 | Jan 6, 2016 | sec.gov |
| Apr 5, 2017 | New notice | $54,000 | $25,200 | $28,800 | 3 | Mar 22, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Katrin I. Andreasson | Director | |
| Mark P. de Souza | Executive Officer, Director | |
| Michelle L. James | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jul 10, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Willow Neuroscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.